Hydrocodone Rescheduling Becomes Official

The U.S. Drug Enforcement Administration’s (DEA) reclassification associated with hydrocodone-combination items coming from Schedule III providers to the much more limited Schedule II is planned to search directly into result nowadays. The particular rescheduling of the mixture providers, which frequently range from the opioid analgesic hydrocodone (a Schedule II drug) and also an over-the-counter soreness

Continue reading Hydrocodone Rescheduling Becomes Official